A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with 18F-FDG PET/CT

Clin Radiol. 2019 Feb;74(2):167.e1-167.e7. doi: 10.1016/j.crad.2018.10.010. Epub 2018 Nov 22.

Abstract

Aim: To compare the performance of machine learning using multiparametric magnetic resonance imaging (mp-MRI) and positron-emission tomography (PET) to distinguish between uterine sarcoma and leiomyoma.

Materials and methods: This retrospective study was approved by the institutional review board and informed consent was waived. Sixty-seven consecutive patients with uterine sarcoma or leiomyoma who underwent pelvic 3 T MRI and PET were included. Of 67 patients, 11 had uterine sarcomas and 56 had leiomyomas. Seven different parameters were measured in the tumours, from T2-weighted, T1-weighted, contrast-enhanced, and diffusion-weighted MRI, and PET. The areas under the receiver operating characteristic curves (AUC) with a leave-one-out cross-validation were used to compare the diagnostic performances of the univariate and multivariate logistic regression (LR) model with those of two board-certified radiologists.

Results: The AUCs of the univariate models using MRI parameters (0.68-0.8) were inferior to that of the maximum standardised uptake value (SUVmax) of PET (0.85); however, the AUC of the multivariate LR model (0.92) was superior to that of SUVmax, and comparable to that of the board-certified radiologists (0.97 and 0.89).

Conclusion: The diagnostic performance of the machine learning using mp-MRI was superior to PET and comparable to that of experienced radiologists.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Diagnosis, Differential
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Image Interpretation, Computer-Assisted / methods
  • Leiomyoma / diagnostic imaging*
  • Machine Learning
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography / methods*
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Retrospective Studies
  • Sarcoma / diagnostic imaging*
  • Sensitivity and Specificity
  • Uterine Neoplasms / diagnostic imaging*
  • Uterus / diagnostic imaging
  • Young Adult

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18